Published in Law and Health Weekly, November 7th, 2009
Investors will also receive warrants to purchase 2,125,334 shares of Rexahn Pharmaceuticals Inc.'s common stock. The warrants have an exercise price of $1.00 per share and are exercisable at any time on or after the closing date and prior to the 5 year...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.